Latest newsLATEST NEWS

We aim to become one of the leading pharmaceutical companies and to do all in our power to help prevent infectious diseases.

2020/11/17
MVC Announced Successful Closing of 1.92 Billion TWD (67.27 Million USD) Follow-on Public Offering
see more
2020/11/10
Medigen and BlueWillow Biologics Partner to Develop Intranasal Vaccine for SARS-COV-2
see more
2020/11/03
MVC and NIHE Partner to Develop COVID-19 Vaccine in Vietnam
see more
2020/10/13
Medigen's COVID-19 Vaccine Combined with Dynavax's CpG 1018 Adjuvant Receives Taiwan Government Subsidy with First Participant Dosed in Early October
see more
2020/09/15
Vaxess Technologies to Develop Coronavirus + Influenza Combo Patch Vaccine in Partnership with Medigen
see more
2020/08/14
Announces Positive Results of Preclinical Data for its vaccine candidate against COVID-19
see more
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies. Our Privacy & Cookie Policy contains more information on such use and explains how to disable cookies.
Agree